Insider Buy/Sell Details for the Biotechnology Industry — October 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (777)
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
1,044,990
Price
$0.02
Total Value
$17.76K
Shares Held After
95,481,309
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$28.27
Total Value
$335.88K
Shares Held After
377,802
% of Holdings
3.0%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
312,000
Price
$0.02
Total Value
$5.77K
Shares Held After
94,436,319
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
200
Price
$28.90
Total Value
$5.78K
Shares Held After
377,802
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,681
Price
$28.44
Total Value
$332.21K
Shares Held After
378,002
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$588.39
Total Value
$47.07K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
986
Price
$587.27
Total Value
$579.04K
Shares Held After
324,523
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,086
Price
$586.37
Total Value
$1.81M
Shares Held After
325,509
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,902
Price
$585.36
Total Value
$1.11M
Shares Held After
328,595
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,625
Price
$584.43
Total Value
$1.53M
Shares Held After
330,497
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
821
Price
$583.50
Total Value
$479.05K
Shares Held After
333,122
% of Holdings
0.2%
ACTUATE THERAPEUTICS, INC. (ACTU)
SCHMITT DANIEL M — Director
Shares
140,844
Price
$0.35
Total Value
$50.00K
Shares Held After
442,560
% of Holdings
31.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
8,881
Price
$27.53
Total Value
$244.49K
Shares Held After
377,802
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,000
Price
$26.58
Total Value
$79.74K
Shares Held After
386,683
% of Holdings
0.8%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
10,707
Price
$2.40
Total Value
$25.70K
Shares Held After
3,022,456
% of Holdings
0.4%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
6,903
Price
$366.22
Total Value
$2.53M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
3,965
Price
$365.43
Total Value
$1.45M
Shares Held After
6,903
% of Holdings
36.5%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
2,841
Price
$363.95
Total Value
$1.03M
Shares Held After
10,868
% of Holdings
20.7%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
8,148
Price
$363.24
Total Value
$2.96M
Shares Held After
13,709
% of Holdings
37.3%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
2,331
Price
$362.35
Total Value
$844.64K
Shares Held After
21,857
% of Holdings
9.6%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
320
Price
$360.64
Total Value
$115.40K
Shares Held After
24,188
% of Holdings
1.3%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,280
Price
$359.72
Total Value
$460.44K
Shares Held After
24,508
% of Holdings
5.0%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,681
Price
$358.75
Total Value
$603.05K
Shares Held After
25,788
% of Holdings
6.1%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,239
Price
$357.54
Total Value
$442.99K
Shares Held After
27,469
% of Holdings
4.3%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
1,440
Price
$355.62
Total Value
$512.09K
Shares Held After
28,708
% of Holdings
4.8%
BeOne Medicines Ltd. (ONC)
Wang Xiaodong — Director
Shares
880
Price
$355.56
Total Value
$312.89K
Shares Held After
30,148
% of Holdings
2.8%
Rallybio Corp (RLYB)
Lieber Jonathan I — Chief Financial Officer
Shares
599
Price
$16.04
Total Value
$9.61K
Shares Held After
15,551
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$592.84
Total Value
$47.43K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$592.05
Total Value
$355.23K
Shares Held After
324,523
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
700
Price
$590.99
Total Value
$413.69K
Shares Held After
325,123
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$589.98
Total Value
$591.75K
Shares Held After
325,823
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,597
Price
$588.95
Total Value
$940.55K
Shares Held After
326,826
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$587.88
Total Value
$776.00K
Shares Held After
328,423
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,417
Price
$586.93
Total Value
$831.67K
Shares Held After
329,743
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
470
Price
$585.72
Total Value
$275.29K
Shares Held After
331,160
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,417
Price
$584.83
Total Value
$828.70K
Shares Held After
331,630
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
807
Price
$583.94
Total Value
$471.24K
Shares Held After
333,047
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
89
Price
$582.66
Total Value
$51.86K
Shares Held After
333,854
% of Holdings
0.0%
VERACYTE, INC. (VCYT)
Holstein Jens — Director
Shares
7,500
Price
$50.00
Total Value
$375.00K
Shares Held After
27,471
% of Holdings
21.4%
VERACYTE, INC. (VCYT)
EASTHAM KARIN — Director
Shares
14,850
Price
$50.00
Total Value
$742.57K
Shares Held After
10,247
% of Holdings
59.2%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,553
Price
$5.10
Total Value
$18.10K
Shares Held After
733,270
% of Holdings
0.5%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
2,310
Price
$186.99
Total Value
$431.95K
Shares Held After
39,765
% of Holdings
5.5%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
1,581
Price
$43.19
Total Value
$68.28K
Shares Held After
164,028
% of Holdings
1.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
7,866
Price
$37.69
Total Value
$296.47K
Shares Held After
54,645
% of Holdings
12.6%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$43.19
Total Value
$29.71K
Shares Held After
177,269
% of Holdings
0.4%
XBiotech Inc. (XBIT)
SIMARD JOHN — Director
Shares
368,524
Price
$1.93
Total Value
$711.25K
Shares Held After
4,191,690
% of Holdings
8.8%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
97,982
Price
$41.59
Total Value
$4.08M
Shares Held After
723,020
% of Holdings
13.6%
Scholar Rock Holding Corp (SRRK)
AKKARAJU SRINIVAS — Director
Shares
48,988
Price
$41.59
Total Value
$2.04M
Shares Held After
6,380,517
% of Holdings
0.8%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,672
Price
$5.03
Total Value
$8.42K
Shares Held After
729,717
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
806
Price
$592.92
Total Value
$477.89K
Shares Held After
324,443
% of Holdings
0.2%
777 transactions